Cavallo Ventures contributed to a series B round for the microbial animal feed producer that will fund product development and recruitment.
US-based animal nutrition product developer Ascus Biosciences completed a $46m series B round on Wednesday that included Cavallo Ventures, the corporate venturing subsidiary of agricultural product and chemical producer Wilbur-Ellis.
The round was led by Singaporean government owned investment firm Temasek and also featured venture capital firm Formation 8 and Anterra Capital, the VC fund backed by financial services firm Rabobank, as well as undisclosed private investors.
Ascus is utilising knowledge of how microbes interact with each other within animals…
